Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by damage to the dopaminergic neurons located in various parts of the brain, including the substantia nigra.
Scope of the Report:
This report focuses on the Parkinson's Disease (PD) Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The emergence of gene therapy to reverse the progression of PD is one of the key trends that will gain traction in the market for parkinsons drugs throughout the estimated period.
The worldwide market for Parkinson's Disease (PD) Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- Boehringer Ingelheim
- GlaxoSmithKline
- Novartis
- Teva Pharmaceutical Industries
- AbbVie
- Abital Pharma
- Addex Therapeutics
- Biogen
- Eisai
- Eli Lilly
- F. Hoffmann-La Roche
- H. Lundbeck
- Impax Laboratories
- Kyowa Hakko Kirin
- Otsuka Pharmaceutical
- Pfizer
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Dopamine Agonist
- Monoamine Oxidase Inhibitors
- Acetylcholinesterase Inhibitors
- Glutamate Inhibitors
Market Segment by Applications, can be divided into
- Hospital
- Family
There are 15 Chapters to deeply display the global Parkinson's Disease (PD) Drugs market.
Chapter 1, to describe Parkinson's Disease (PD) Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Parkinson's Disease (PD) Drugs, with sales, revenue, and price of Parkinson's Disease (PD) Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Parkinson's Disease (PD) Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Parkinson's Disease (PD) Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Parkinson's Disease (PD) Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Global Parkinson's Disease (PD) Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
Table of Contents
1 Market Overview
1.1 Parkinson's Disease (PD) Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Dopamine Agonist
1.2.2 Monoamine Oxidase Inhibitors
1.2.3 Acetylcholinesterase Inhibitors
1.2.4 Glutamate Inhibitors
1.3 Market Analysis by Applications
1.3.1 Hospital
1.3.2 Family
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Boehringer Ingelheim
2.1.1 Business Overview
2.1.2 Parkinson's Disease (PD) Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 GlaxoSmithKline
2.2.1 Business Overview
2.2.2 Parkinson's Disease (PD) Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Novartis
2.3.1 Business Overview
2.3.2 Parkinson's Disease (PD) Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Novartis Parkinson's Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Teva Pharmaceutical Industries
2.4.1 Business Overview
2.4.2 Parkinson's Disease (PD) Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 AbbVie
2.5.1 Business Overview
2.5.2 Parkinson's Disease (PD) Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 AbbVie Parkinson's Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Abital Pharma
2.6.1 Business Overview
2.6.2 Parkinson's Disease (PD) Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Abital Pharma Parkinson's Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Addex Therapeutics
2.7.1 Business Overview
2.7.2 Parkinson's Disease (PD) Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Addex Therapeutics Parkinson's Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Biogen
2.8.1 Business Overview
2.8.2 Parkinson's Disease (PD) Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Biogen Parkinson's Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Eisai
2.9.1 Business Overview
2.9.2 Parkinson's Disease (PD) Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Eisai Parkinson's Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Eli Lilly
2.10.1 Business Overview
2.10.2 Parkinson's Disease (PD) Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Eli Lilly Parkinson's Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 F. Hoffmann-La Roche
2.11.1 Business Overview
2.11.2 Parkinson's Disease (PD) Drugs Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 H. Lundbeck
2.12.1 Business Overview
2.12.2 Parkinson's Disease (PD) Drugs Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 H. Lundbeck Parkinson's Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Impax Laboratories
2.13.1 Business Overview
2.13.2 Parkinson's Disease (PD) Drugs Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Impax Laboratories Parkinson's Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Kyowa Hakko Kirin
2.14.1 Business Overview
2.14.2 Parkinson's Disease (PD) Drugs Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Otsuka Pharmaceutical
2.15.1 Business Overview
2.15.2 Parkinson's Disease (PD) Drugs Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Pfizer
2.16.1 Business Overview
2.16.2 Parkinson's Disease (PD) Drugs Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Pfizer Parkinson's Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Parkinson's Disease (PD) Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Parkinson's Disease (PD) Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Parkinson's Disease (PD) Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Parkinson's Disease (PD) Drugs Manufacturer Market Share in 2017
3.3.2 Top 6 Parkinson's Disease (PD) Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Parkinson's Disease (PD) Drugs Market Analysis by Regions
4.1 Global Parkinson's Disease (PD) Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Parkinson's Disease (PD) Drugs Sales and Market Share by Regions (2013-2018)
4.1.2 Global Parkinson's Disease (PD) Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Parkinson's Disease (PD) Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Parkinson's Disease (PD) Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Parkinson's Disease (PD) Drugs Sales and Growth Rate (2013-2018)
4.5 South America Parkinson's Disease (PD) Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Parkinson's Disease (PD) Drugs Sales and Growth Rate (2013-2018)
5 North America Parkinson's Disease (PD) Drugs by Countries
5.1 North America Parkinson's Disease (PD) Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Parkinson's Disease (PD) Drugs Sales and Market Share by Countries (2013-2018)
5.1.2 North America Parkinson's Disease (PD) Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Parkinson's Disease (PD) Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Parkinson's Disease (PD) Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Parkinson's Disease (PD) Drugs Sales and Growth Rate (2013-2018)
6 Europe Parkinson's Disease (PD) Drugs by Countries
6.1 Europe Parkinson's Disease (PD) Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Parkinson's Disease (PD) Drugs Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Parkinson's Disease (PD) Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Parkinson's Disease (PD) Drugs Sales and Growth Rate (2013-2018)
6.3 UK Parkinson's Disease (PD) Drugs Sales and Growth Rate (2013-2018)
6.4 France Parkinson's Disease (PD) Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Parkinson's Disease (PD) Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Parkinson's Disease (PD) Drugs Sales and Growth Rate (2013-2018)
7 Asia-Pacific Parkinson's Disease (PD) Drugs by Countries
7.1 Asia-Pacific Parkinson's Disease (PD) Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Parkinson's Disease (PD) Drugs Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Parkinson's Disease (PD) Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Parkinson's Disease (PD) Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Parkinson's Disease (PD) Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Parkinson's Disease (PD) Drugs Sales and Growth Rate (2013-2018)
7.5 India Parkinson's Disease (PD) Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Parkinson's Disease (PD) Drugs Sales and Growth Rate (2013-2018)
8 South America Parkinson's Disease (PD) Drugs by Countries
8.1 South America Parkinson's Disease (PD) Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Parkinson's Disease (PD) Drugs Sales and Market Share by Countries (2013-2018)
8.1.2 South America Parkinson's Disease (PD) Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Parkinson's Disease (PD) Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Parkinson's Disease (PD) Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Parkinson's Disease (PD) Drugs Sales and Growth Rate (2013-2018)
9 Middle East and Africa Parkinson's Disease (PD) Drugs by Countries
9.1 Middle East and Africa Parkinson's Disease (PD) Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Parkinson's Disease (PD) Drugs Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Parkinson's Disease (PD) Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Parkinson's Disease (PD) Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Parkinson's Disease (PD) Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Parkinson's Disease (PD) Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Parkinson's Disease (PD) Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Parkinson's Disease (PD) Drugs Sales and Growth Rate (2013-2018)
10 Global Parkinson's Disease (PD) Drugs Market Segment by Type
10.1 Global Parkinson's Disease (PD) Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Parkinson's Disease (PD) Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Parkinson's Disease (PD) Drugs Revenue and Market Share by Type (2013-2018)
10.2 Dopamine Agonist Sales Growth and Price
10.2.1 Global Dopamine Agonist Sales Growth (2013-2018)
10.2.2 Global Dopamine Agonist Price (2013-2018)
10.3 Monoamine Oxidase Inhibitors Sales Growth and Price
10.3.1 Global Monoamine Oxidase Inhibitors Sales Growth (2013-2018)
10.3.2 Global Monoamine Oxidase Inhibitors Price (2013-2018)
10.4 Acetylcholinesterase Inhibitors Sales Growth and Price
10.4.1 Global Acetylcholinesterase Inhibitors Sales Growth (2013-2018)
10.4.2 Global Acetylcholinesterase Inhibitors Price (2013-2018)
10.5 Glutamate Inhibitors Sales Growth and Price
10.5.1 Global Glutamate Inhibitors Sales Growth (2013-2018)
10.5.2 Global Glutamate Inhibitors Price (2013-2018)
11 Global Parkinson's Disease (PD) Drugs Market Segment by Application
11.1 Global Parkinson's Disease (PD) Drugs Sales Market Share by Application (2013-2018)
11.2 Hospital Sales Growth (2013-2018)
11.3 Family Sales Growth (2013-2018)
12 Parkinson's Disease (PD) Drugs Market Forecast (2018-2023)
12.1 Global Parkinson's Disease (PD) Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Parkinson's Disease (PD) Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Parkinson's Disease (PD) Drugs Market Forecast (2018-2023)
12.2.2 Europe Parkinson's Disease (PD) Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Parkinson's Disease (PD) Drugs Market Forecast (2018-2023)
12.2.4 South America Parkinson's Disease (PD) Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Parkinson's Disease (PD) Drugs Market Forecast (2018-2023)
12.3 Parkinson's Disease (PD) Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Parkinson's Disease (PD) Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Parkinson's Disease (PD) Drugs Market Share Forecast by Type (2018-2023)
12.4 Parkinson's Disease (PD) Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Parkinson's Disease (PD) Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Parkinson's Disease (PD) Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Parkinson's Disease (PD) Drugs Picture
Table Product Specifications of Parkinson's Disease (PD) Drugs
Figure Global Sales Market Share of Parkinson's Disease (PD) Drugs by Types in 2017
Table Parkinson's Disease (PD) Drugs Types for Major Manufacturers
Figure Dopamine Agonist Picture
Figure Monoamine Oxidase Inhibitors Picture
Figure Acetylcholinesterase Inhibitors Picture
Figure Glutamate Inhibitors Picture
Figure Parkinson's Disease (PD) Drugs Sales Market Share by Applications in 2017
Figure Hospital Picture
Figure Family Picture
Figure United States Parkinson's Disease (PD) Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Parkinson's Disease (PD) Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Parkinson's Disease (PD) Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Parkinson's Disease (PD) Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure France Parkinson's Disease (PD) Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure UK Parkinson's Disease (PD) Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Parkinson's Disease (PD) Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Parkinson's Disease (PD) Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure China Parkinson's Disease (PD) Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Parkinson's Disease (PD) Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Parkinson's Disease (PD) Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure India Parkinson's Disease (PD) Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Parkinson's Disease (PD) Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Parkinson's Disease (PD) Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Parkinson's Disease (PD) Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Parkinson's Disease (PD) Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Parkinson's Disease (PD) Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Parkinson's Disease (PD) Drugs Revenue (Value) and Growth Rate (2013-2023)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim Parkinson's Disease (PD) Drugs Type and Applications
Table Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Parkinson's Disease (PD) Drugs Type and Applications
Table GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Parkinson's Disease (PD) Drugs Type and Applications
Table Novartis Parkinson's Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Type and Applications
Table Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AbbVie Basic Information, Manufacturing Base and Competitors
Table AbbVie Parkinson's Disease (PD) Drugs Type and Applications
Table AbbVie Parkinson's Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Abital Pharma Basic Information, Manufacturing Base and Competitors
Table Abital Pharma Parkinson's Disease (PD) Drugs Type and Applications
Table Abital Pharma Parkinson's Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Addex Therapeutics Basic Information, Manufacturing Base and Competitors
Table Addex Therapeutics Parkinson's Disease (PD) Drugs Type and Applications
Table Addex Therapeutics Parkinson's Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Biogen Basic Information, Manufacturing Base and Competitors
Table Biogen Parkinson's Disease (PD) Drugs Type and Applications
Table Biogen Parkinson's Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Eisai Basic Information, Manufacturing Base and Competitors
Table Eisai Parkinson's Disease (PD) Drugs Type and Applications
Table Eisai Parkinson's Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Parkinson's Disease (PD) Drugs Type and Applications
Table Eli Lilly Parkinson's Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Type and Applications
Table F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table H. Lundbeck Basic Information, Manufacturing Base and Competitors
Table H. Lundbeck Parkinson's Disease (PD) Drugs Type and Applications
Table H. Lundbeck Parkinson's Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Impax Laboratories Basic Information, Manufacturing Base and Competitors
Table Impax Laboratories Parkinson's Disease (PD) Drugs Type and Applications
Table Impax Laboratories Parkinson's Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Kyowa Hakko Kirin Basic Information, Manufacturing Base and Competitors
Table Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Type and Applications
Table Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Otsuka Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Type and Applications
Table Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Parkinson's Disease (PD) Drugs Type and Applications
Table Pfizer Parkinson's Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Parkinson's Disease (PD) Drugs Sales by Manufacturer (2016-2017)
Figure Global Parkinson's Disease (PD) Drugs Sales Market Share by Manufacturer in 2016
Figure Global Parkinson's Disease (PD) Drugs Sales Market Share by Manufacturer in 2017
Table Global Parkinson's Disease (PD) Drugs Revenue by Manufacturer (2016-2017)
Figure Global Parkinson's Disease (PD) Drugs Revenue Market Share by Manufacturer in 2016
Figure Global Parkinson's Disease (PD) Drugs Revenue Market Share by Manufacturer in 2017
Figure Top 3 Parkinson's Disease (PD) Drugs Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Parkinson's Disease (PD) Drugs Manufacturer (Revenue) Market Share in 2017
Figure Global Parkinson's Disease (PD) Drugs Sales and Growth Rate (2013-2018)
Figure Global Parkinson's Disease (PD) Drugs Revenue and Growth Rate (2013-2018)
Table Global Parkinson's Disease (PD) Drugs Sales by Regions (2013-2018)
Table Global Parkinson's Disease (PD) Drugs Sales Market Share by Regions (2013-2018)
Table Global Parkinson's Disease (PD) Drugs Revenue by Regions (2013-2018)
Figure Global Parkinson's Disease (PD) Drugs Revenue Market Share by Regions in 2013
Figure Global Parkinson's Disease (PD) Drugs Revenue Market Share by Regions in 2017
Figure North America Parkinson's Disease (PD) Drugs Sales and Growth Rate (2013-2018)
Figure Europe Parkinson's Disease (PD) Drugs Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Parkinson's Disease (PD) Drugs Sales and Growth Rate (2013-2018)
Figure South America Parkinson's Disease (PD) Drugs Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Parkinson's Disease (PD) Drugs Sales and Growth Rate (2013-2018)
Figure North America Parkinson's Disease (PD) Drugs Revenue and Growth Rate (2013-2018)
Table North America Parkinson's Disease (PD) Drugs Sales by Countries (2013-2018)
Table North America Parkinson's Disease (PD) Drugs Sales Market Share by Countries (2013-2018)
Figure North America Parkinson's Disease (PD) Drugs Sales Market Share by Countries in 2013
Figure North America Parkinson's Disease (PD) Drugs Sales Market Share by Countries in 2017
Table North America Parkinson's Disease (PD) Drugs Revenue by Countries (2013-2018)
Table North America Parkinson's Disease (PD) Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Parkinson's Disease (PD) Drugs Revenue Market Share by Countries in 2013
Figure North America Parkinson's Disease (PD) Drugs Revenue Market Share by Countries in 2017
Figure United States Parkinson's Disease (PD) Drugs Sales and Growth Rate (2013-2018)
Figure Canada Parkinson's Disease (PD) Drugs Sales and Growth Rate (2013-2018)
Figure Mexico Parkinson's Disease (PD) Drugs Sales and Growth Rate (2013-2018)
Figure Europe Parkinson's Disease (PD) Drugs Revenue and Growth Rate (2013-2018)
Table Europe Parkinson's Disease (PD) Drugs Sales by Countries (2013-2018)
Table Europe Parkinson's Disease (PD) Drugs Sales Market Share by Countries (2013-2018)
Table Europe Parkinson's Disease (PD) Drugs Revenue by Countries (2013-2018)
Figure Europe Parkinson's Disease (PD) Drugs Revenue Market Share by Countries in 2016
Figure Europe Parkinson's Disease (PD) Drugs Revenue Market Share by Countries in 2017
Figure Germany Parkinson's Disease (PD) Drugs Sales and Growth Rate (2013-2018)
Figure UK Parkinson's Disease (PD) Drugs Sales and Growth Rate (2013-2018)
Figure France Parkinson's Disease (PD) Drugs Sales and Growth Rate (2013-2018)
Figure Russia Parkinson's Disease (PD) Drugs Sales and Growth Rate (2013-2018)
Figure Italy Parkinson's Disease (PD) Drugs Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Parkinson's Disease (PD) Drugs Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Parkinson's Disease (PD) Drugs Sales by Countries (2013-2018)
Table Asia-Pacific Parkinson's Disease (PD) Drugs Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Parkinson's Disease (PD) Drugs Sales Market Share by Countries 2017
Table Asia-Pacific Parkinson's Disease (PD) Drugs Revenue by Countries (2013-2018)
Figure Asia-Pacific Parkinson's Disease (PD) Drugs Revenue Market Share by Countries 2017
Figure China Parkinson's Disease (PD) Drugs Sales and Growth Rate (2013-2018)
Figure Japan Parkinson's Disease (PD) Drugs Sales and Growth Rate (2013-2018)
Figure Korea Parkinson's Disease (PD) Drugs Sales and Growth Rate (2013-2018)
Figure India Parkinson's Disease (PD) Drugs Sales and Growth Rate (2013-2018)
Figure Southeast Asia Parkinson's Disease (PD) Drugs Sales and Growth Rate (2013-2018)
Figure South America Parkinson's Disease (PD) Drugs Revenue and Growth Rate (2013-2018)
Table South America Parkinson's Disease (PD) Drugs Sales by Countries (2013-2018)
Table South America Parkinson's Disease (PD) Drugs Sales Market Share by Countries (2013-2018)
Figure South America Parkinson's Disease (PD) Drugs Sales Market Share by Countries in 2017
Table South America Parkinson's Disease (PD) Drugs Revenue by Countries (2013-2018)
Table South America Parkinson's Disease (PD) Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Parkinson's Disease (PD) Drugs Revenue Market Share by Countries in 2017
Figure Brazil Parkinson's Disease (PD) Drugs Sales and Growth Rate (2013-2018)
Figure Argentina Parkinson's Disease (PD) Drugs Sales and Growth Rate (2013-2018)
Figure Colombia Parkinson's Disease (PD) Drugs Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Parkinson's Disease (PD) Drugs Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Parkinson's Disease (PD) Drugs Sales by Countries (2013-2018)
Table Middle East and Africa Parkinson's Disease (PD) Drugs Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Parkinson's Disease (PD) Drugs Sales Market Share by Countries in 2017
Table Middle East and Africa Parkinson's Disease (PD) Drugs Revenue by Countries (2013-2018)
Table Middle East and Africa Parkinson's Disease (PD) Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Parkinson's Disease (PD) Drugs Revenue Market Share by Countries in 2013
Figure Middle East and Africa Parkinson's Disease (PD) Drugs Revenue Market Share by Countries in 2017
Figure Saudi Arabia Parkinson's Disease (PD) Drugs Sales and Growth Rate (2013-2018)
Figure UAE Parkinson's Disease (PD) Drugs Sales and Growth Rate (2013-2018)
Figure Egypt Parkinson's Disease (PD) Drugs Sales and Growth Rate (2013-2018)
Figure Nigeria Parkinson's Disease (PD) Drugs Sales and Growth Rate (2013-2018)
Figure South Africa Parkinson's Disease (PD) Drugs Sales and Growth Rate (2013-2018)
Table Global Parkinson's Disease (PD) Drugs Sales by Type (2013-2018)
Table Global Parkinson's Disease (PD) Drugs Sales Share by Type (2013-2018)
Table Global Parkinson's Disease (PD) Drugs Revenue by Type (2013-2018)
Table Global Parkinson's Disease (PD) Drugs Revenue Share by Type (2013-2018)
Figure Global Dopamine Agonist Sales Growth (2013-2018)
Figure Global Dopamine Agonist Price (2013-2018)
Figure Global Monoamine Oxidase Inhibitors Sales Growth (2013-2018)
Figure Global Monoamine Oxidase Inhibitors Price (2013-2018)
Figure Global Acetylcholinesterase Inhibitors Sales Growth (2013-2018)
Figure Global Acetylcholinesterase Inhibitors Price (2013-2018)
Figure Global Glutamate Inhibitors Sales Growth (2013-2018)
Figure Global Glutamate Inhibitors Price (2013-2018)
Table Global Parkinson's Disease (PD) Drugs Sales by Application (2013-2018)
Table Global Parkinson's Disease (PD) Drugs Sales Share by Application (2013-2018)
Figure Global Family Sales Growth (2013-2018)
Figure Global Parkinson's Disease (PD) Drugs Sales, Revenue and Growth Rate (2018-2023)
Table Global Parkinson's Disease (PD) Drugs Sales Forecast by Regions (2018-2023)
Table Global Parkinson's Disease (PD) Drugs Market Share Forecast by Regions (2018-2023)
Figure North America Sales Parkinson's Disease (PD) Drugs Market Forecast (2018-2023)
Figure Europe Sales Parkinson's Disease (PD) Drugs Market Forecast (2018-2023)
Figure Asia-Pacific Sales Parkinson's Disease (PD) Drugs Market Forecast (2018-2023)
Figure South America Sales Parkinson's Disease (PD) Drugs Market Forecast (2018-2023)
Figure Middle East and Africa Sales Parkinson's Disease (PD) Drugs Market Forecast (2018-2023)
Table Global Parkinson's Disease (PD) Drugs Sales Forecast by Type (2018-2023)
Table Global Parkinson's Disease (PD) Drugs Market Share Forecast by Type (2018-2023)
Table Global Parkinson's Disease (PD) Drugs Sales Forecast by Application (2018-2023)
Table Global Parkinson's Disease (PD) Drugs Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
Global Parkinson's Disease Therapeutics Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 99
Parkinson's disease (PD), or simply Parkinson's, is a chronic degenerative disorder of The central nervous system that affects both The motor system and non-motor systems. The symptoms usually emerge slowly, and as The disease worsens, non-motor symptoms become more common. Early symptoms are tremor, rigidity, slowness of movement, and difficulty with walking. Problems may also arise with cognition, behaviour, sleep, and sensory systems. Parkinson's disease dementia becomes common in advanced st......
Global Amantadine Hydrochloride Market Insights, Forecast to 2029
Published: 29-Aug-2023 Price: US 4900 Onwards Pages: 109
Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder.
The global Amantadine Hydrochloride market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Amantadine hydrochloride is clinically effective in preventing and treating infections of various influenza A viruses. In the influenza epidemic period, this product is use......
Global Rasagiline Tablet Market Insights, Forecast to 2029
Published: 11-Aug-2023 Price: US 4900 Onwards Pages: 107
Rasagiline (Azilect, Azipron) is an irreversible inhibitor of monoamine oxidase-B used as a monotherapy to treat symptoms in early Parkinson's disease or as an adjunct therapy in more advanced cases.
The global Rasagiline Tablet market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The racemic form of the drug was invented by Aspro Nicholas in the early 1970s. Moussa B.H. Youdim identifi......
Global Parkinsons Disease Drug Market Insights, Forecast to 2029
Published: 02-Aug-2023 Price: US 4900 Onwards Pages: 113
Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement.
The global Parkinsons Disease Drug market is projected to grow from US$ 5763.6 million in 2023 to US$ 7419.9 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period.
Global P......
Global Rasagiline Tablet Market Research Report 2023, Forecast to 2028
Published: 20-Mar-2023 Price: US 2680 Onwards Pages: 137
Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness).
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......
Global Rasagiline Tablet Professional Survey Report 2023, Forecast to 2028
Published: 20-Mar-2023 Price: US 3280 Onwards Pages: 109
Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness).
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......
Global Amantadine Hydrochloride Market Research Report 2023
Published: 09-Mar-2023 Price: US 2900 Onwards Pages: 98
Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder.
Highlights
The global Amantadine Hydrochloride market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
Amantadine hydrochloride is clinically effective......
Global Parkinson's Disease (PD) Drugs Professional Survey Report 2023, Forecast to 2028
Published: 21-Feb-2023 Price: US 3280 Onwards Pages: 133
Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......
Global Parkinson's Disease (PD) Drugs Market Research Report 2023, Forecast to 2028
Published: 21-Feb-2023 Price: US 2680 Onwards Pages: 159
Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
